DoD Bone Marrow Failure, Investigator-Initiated Research Award
ID: 354817Type: Posted
Overview

Buyer

Dept. of the Army -- USAMRAA (DOD-AMRAA)

Eligible Applicants

Unrestricted

Funding Category

Science and Technology and other Research and Development

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes
Timeline
    Description

    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the FY24 Bone Marrow Failure Investigator-Initiated Research Award (IIRA) to support innovative research addressing bone marrow failure (BMF) diseases. This grant aims to fund studies that enhance understanding of BMF conditions, such as aplastic anemia and Fanconi anemia, and to develop effective treatments and cures, with a total funding allocation of $2.44 million for the fiscal year 2024. Eligible applicants include both extramural and intramural organizations, with a requirement for researchers to hold the position of Assistant Professor or higher, and the application process involves a pre-application due by July 17, 2024, followed by a full application due by October 9, 2024. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.

    Point(s) of Contact
    Files
    Title
    Posted
    The DOD FY24 Bone Marrow Failure Investigator-Initiated Research Award aims to fund innovative research addressing bone marrow failure (BMF) diseases. This federal grant, under the Congressionally Directed Medical Research Programs, has an allocation of $7.5 million for the fiscal year 2024. The funding opportunity seeks applications focusing on understanding the causes and progression of BMF diseases, as well as finding effective treatments and cures. The program prioritizes research on specific BMF conditions, such as aplastic anemia and Fanconi anemia. The application process requires two submissions: a pre-application by July 17, 2024, and a full application by October 9, 2024. There are two funding levels, with limits of $675,000 for early development studies and $850,000 for IND application-enabling efforts. Eligible applicants include both extramural and intramural organizations, with a requirement for researchers to hold the position of Assistant Professor or higher. The document outlines detailed submission guidelines, evaluation criteria, and the need for multidisciplinary collaboration to enhance research impact and translational potential. It stresses rigorous study design while fostering innovative approaches within the scientific community to improve BMF disease outcomes.
    Similar Opportunities
    BROAD AGENCY ANNOUNCEMENT (BAA) for Extramural Biomedical and Human Performance Research and Development Department of Defense
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research Acquisition Activity (USAMRAA), has announced a Broad Agency Announcement (BAA) for Extramural Biomedical and Human Performance Research and Development. This opportunity invites unrestricted applicants to submit proposals aimed at advancing biomedical research and development, with a focus on enhancing human performance. The program is critical for fostering innovation in science and technology, particularly in areas that support the Department of Defense's mission. The estimated total program funding is $10 million, with individual awards ranging from $750,000 to $50 million, and proposals are due by July 31, 2028. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or by phone at 301-682-5507.
    Airman Readiness Medical Research (ARMR) Hybrid BAA
    Air Force -- Research Lab
    The Air Force Research Laboratory (AFRL) is soliciting proposals for the Airman Readiness Medical Research (ARMR) program through a Hybrid Broad Agency Announcement (BAA) designated FA8650-20-S-6008. The primary objectives of this initiative are to conduct medical research aimed at optimizing the health and performance of Airmen, focusing on ensuring medical availability and understanding the effects of various operational environments on Airman well-being. This program is critical for enhancing the operational readiness of military personnel, particularly in high-demand mission scenarios, with key research areas including aeromedical evacuation, cognitive performance, and exposure health. The total funding available for this program is estimated at $480 million, with individual awards ranging from $50,000 to $49 million. Interested parties are encouraged to submit white papers by May 1, 2025, and can direct inquiries to Amber A. Taylor at amber.taylor.9@us.af.mil.
    NFRP Outreach and Invitation for Response
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research Acquisition Activity (USAMRAA), is forecasting an opportunity for a Research-based Other Transactions Agreement (rOTA) under the Neurofibromatosis Research Program (NFRP). This initiative aims to accelerate the clinical translation of basic research related to neurofibromatosis (NF) by conducting collaborative Phase I and II clinical trials focused on promising therapeutic agents for NF1, NF2, and schwannomatosis. Historically, this requirement has been addressed through assistance agreements, and the government is now seeking feedback on this proposed approach, emphasizing the need for cost-sharing arrangements and access to patient populations. Interested parties can direct inquiries to Jason D. Kuhns at jason.d.kuhns.civ@mail.mil, with the opportunity being part of the FY21 portfolio and requiring a demonstrated history of collaborative research among participants.
    Fiscal Year (FY) 2026 Department of Defense Multidisciplinary Research Program of the University Research Initiative (MURI) Department of Defense Army
    Dept of the Army -- Materiel Command
    The Department of the Army's Materiel Command is offering a funding opportunity through the Fiscal Year 2026 Multidisciplinary Research Program of the University Research Initiative (MURI), aimed at fostering innovative research with military applications. This program invites proposals exclusively from U.S. institutions of higher education, including universities with degree-granting programs in science and engineering, to conduct high-risk basic research that addresses significant scientific challenges. With an estimated total program funding of $170 million over five years, the MURI program will support annual grants of up to $1.5 million, with proposals due by September 5, 2025, and optional white papers due by May 2, 2025. Interested applicants can reach out to Dr. Sue Kase at usarmy.rtp.devcom-arl.mbx.aro-muri@army.mil for further information.
    FY 25 DOD HBCU/MI Equipment/Instrumentation
    Dept of the Army -- Materiel Command
    The Department of the Army's Materiel Command is inviting applications for the Fiscal Year 2025 Research and Education Program aimed at Historically Black Colleges and Universities and Minority-Serving Institutions (HBCUs/MIs). The program seeks to enhance research capabilities and strengthen STEM education by providing grants for the acquisition of critical equipment and instrumentation, with funding ranging from $200,000 to $1,000,000. This initiative is vital for fostering research ecosystems within HBCUs/MIs and promoting student engagement in STEM fields, although funding cannot be used for student support or general-purpose equipment. Interested institutions must submit their applications via Grants.gov by April 28, 2025, and can direct inquiries to William A. Creech at william.a.creech3.civ@army.mil or by phone at 919-549-4387.
    U.S. Army Research Institute for the Behavioral and Social Sciences Broad Agency Announcement for Basic Research (Fiscal Year 2026)
    Dept of the Army -- Materiel Command
    The Department of the Army, through the U.S. Army Research Institute for the Behavioral and Social Sciences (ARI), is inviting proposals for its Broad Agency Announcement (BAA) for basic research in fiscal year 2026. The initiative seeks to advance foundational research in four strategic areas: Measurement of Individuals and Collectives, Teams and Small Groups, Organizations and Systems, and Formal and Informal Learning and Development, aimed at enhancing personnel readiness and performance in alignment with Army modernization priorities. Eligible applicants include institutions of higher education, non-profit organizations, and commercial entities, with funding provided via grants and cooperative agreements. White papers are due by March 9, 2025, and final proposals must be submitted by July 1, 2025, with anticipated awards ranging from October 2025 to September 2026. For inquiries, contact Wilveria A. Sanders at wilveria.a.sanders.civ@army.mil or by phone at 803-968-1625.
    Tactical Behaviors for Autonomous Maneuver
    Dept of the Army -- Materiel Command
    The Department of the Army's Materiel Command is offering a funding opportunity through the Tactical Behaviors for Autonomous Maneuver Collaborative Research Program (TBAM-CRP) aimed at enhancing the capabilities of robotic and autonomous systems (RAS) for military operations in complex environments. This program seeks proposals that develop coordinated and adaptive behaviors for small groups of autonomous agents, focusing on innovative maneuver tactics and strategies to operate effectively in multi-domain operations against peer adversaries. The TBAM-CRP is critical for advancing military capabilities, leveraging new technologies in robotics and autonomous systems to improve situational awareness and operational effectiveness on the battlefield. Interested applicants, including institutions of higher education and for-profit organizations, are invited to submit proposals by April 24, 2024, with funding amounts ranging from $100,000 to $2.3 million available per award. For further inquiries, applicants can contact Christopher D. Justice at usarmy.adelphi.devcom-arl.mbx.tbam-crp-questions@army.mil.
    Department of Army Energetics Basic Research Center (EBRC) Fiscal Year 2025
    Dept of the Army -- Materiel Command
    The Department of the Army, through the Materiel Command, is offering a funding opportunity for the Energetics Basic Research Center (EBRC) for Fiscal Year 2025, aimed at advancing research in energetic materials (EM) critical to U.S. national security. This initiative invites eligible applicants, including universities, nonprofit organizations, state and local governments, and for-profit entities, to submit white papers and proposals that focus on innovative research in EMs, particularly in areas such as novel materials, microstructure influence, and advanced diagnostics. The program is designed to enhance the Army's capabilities in developing new materials and technologies that improve weapon systems' performance and effectiveness, with a total funding ceiling of $1 million anticipated for up to six awards ranging from $60,000 to $250,000 per year. Interested parties should submit white papers by January 6, 2025, and proposals by invitation by April 7, 2025; for further inquiries, contact Schon Zwakman at schon.m.zwakman.civ@army.mil or by phone at 919-541-4722.
    Stimulating Hematology Investigation: New Endeavors (SHINE) (R01 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Stimulating Hematology Investigation: New Endeavors (SHINE)" aimed at promoting innovative research in non-malignant hematology. This initiative invites investigator-initiated research project grant applications (R01) that focus on basic and early translational hematology research, with a particular emphasis on fostering diverse perspectives within research teams through a required Plan for Enhancing Diverse Perspectives (PEDP). Approximately $2.5 million is available for 5-8 awards, with applications due by February 5, 2025. Interested applicants can find more information and contact NIH Grants Information at grantsinfo@nih.gov for inquiries.
    Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting grant applications for the opportunity titled "Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)." This funding initiative aims to support exploratory research projects focused on the early-stage development of innovative technologies that enhance the quality, handling, and preservation of cancer-related biospecimens, addressing issues such as pre-analytical degradation. The initiative is part of the broader Innovative Molecular Analysis Technologies (IMAT) Program and seeks to advance cancer research, early detection, and treatment while addressing health disparities. Eligible applicants include a diverse range of institutions and organizations, with a maximum funding amount of $150,000 per year for up to three years. The application deadline is October 3, 2025, and interested parties can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.